More than five million people in the United States have been
diagnosed with AD. By 2050, barring breakthroughs in prevention
or treatment, about 16 million will be affected. New guidelines
for diagnosing Alzheimer's disease are intended to support the
emerging theory that the disease is present in the body long
before it manifests in diminished cognitive capacity.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.